AU:RCE Stock Latest News
Company AnnouncementsRecce Pharmaceuticals Issues 85,041 Ordinary Shares18h ago
Company AnnouncementsRecce Pharmaceuticals Applies to Quote 85,041 Ordinary Shares18h ago
Company AnnouncementsRecce Pharmaceuticals Notifies 5,124,999 Unquoted Options for Issue3d ago
Company AnnouncementsRecce Director McKeough Discloses Final Shareholdings1w ago
Company AnnouncementsRecce Pharmaceuticals Reports 2026 AGM Poll Results1w ago
Company AnnouncementsRecce AGM Presentation Provides No Substantive Business Update1w ago
Company AnnouncementsRecce Pharmaceuticals Issues New Shares in Compliant Capital Move2w ago
Company AnnouncementsRecce Pharmaceuticals Seeks ASX Quotation for New Employee Incentive Shares2w ago
Company AnnouncementsRecce strengthens Phase 3 DFI program and expands anti-infective IP in Vietnam2w ago
Company AnnouncementsRecce and Arrotex Strike Exclusive Deal for Diabetic Foot Infection Gel3w ago
Company AnnouncementsRecce Faces Key DMC Review as Phase 3 Diabetic Foot Gel Trial Shows Strong Signals4w agoCompany AnnouncementsRecce Pharmaceuticals Sets 2026 AGM as Synthetic Anti-Infective Pipeline Gains Recognition1M ago
Company AnnouncementsRecce Pharmaceuticals faces shareholder push for governance changes and board shake-up1M ago
Company AnnouncementsRecce Sets 2026 AGM Date as It Advances Synthetic Anti-Infective Pipeline1M ago
Company AnnouncementsRecce Investors Reject Option Issues and Placement Ratification at General Meeting2M ago
Company AnnouncementsRecce Pharmaceuticals Issues Investor Presentation with Extensive Legal Disclaimers2M ago
Company AnnouncementsRecce Pharmaceuticals Files ASX Corporate Governance Statement and Appendix 4G2M agoCompany AnnouncementsRecce Pharmaceuticals Narrows Loss as Global Anti-Infective Programs Advance2M ago
Company AnnouncementsRecce wins Australian approval to expand pivotal Phase 3 diabetic foot trial3M ago



